EXACT SCIEN. DL-,01EXACT SCIEN. DL-,01EXACT SCIEN. DL-,01

EXACT SCIEN. DL-,01

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.44EUR
Revenue estimate
‪581.42 M‬EUR
Market capitalization
‪9.95 B‬EUR
−1.03EUR
‪−184.96 M‬EUR
‪2.26 B‬EUR
‪179.65 M‬
Beta (1Y)
1.89

About Exact Sciences Corporation

CEO
Kevin T. Conroy
Headquarters
Madison
Employees (FY)
‪6.6 K‬
Founded
1995
FIGI
BBG003MS7W09
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EXACT SCIEN. DL-,01 stocks are traded under the ticker EXK.
EXACT SCIEN. DL-,01 is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
EXACT SCIEN. DL-,01 revenue for the last quarter amounts to ‪594.40 M‬ EUR despite the estimated figure of ‪583.48 M‬ EUR. In the next quarter revenue is expected to reach ‪578.79 M‬ EUR.
Yes, you can track EXACT SCIEN. DL-,01 financials in yearly and quarterly reports right on TradingView.
EXK net income for the last quarter is ‪−45.09 M‬ EUR, while the quarter before that showed ‪751.12 K‬ EUR of net income which accounts for ‪−6.10 K‬% change. Track more EXACT SCIEN. DL-,01 financial stats to get the full picture.
No, EXK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EXK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXACT SCIEN. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
EXK reached its all-time high on Feb 15, 2021 with the price of 129.46 EUR, and its all-time low was 0.22 EUR and was reached on Dec 17, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has ‪6.60 K‬ employees. See our rating of the largest employees — is EXACT SCIEN. DL-,01 on this list?
We've gathered analysts' opinions on EXACT SCIEN. DL-,01 future price: according to them, EXK price has a max estimate of 107.95 EUR and a min estimate of 61.96 EUR. Read a more detailed EXACT SCIEN. DL-,01 forecast: see what analysts think of EXACT SCIEN. DL-,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXACT SCIEN. DL-,01 EBITDA is ‪−70.19 M‬ EUR, and current EBITDA margin is −3.05%. See more stats in EXACT SCIEN. DL-,01 financial statements.